Product NDC: | 52544-473 |
Proprietary Name: | Alora |
Non Proprietary Name: | Estradiol Transdermal System |
Active Ingredient(s): | .1 mg/d & nbsp; Estradiol Transdermal System |
Administration Route(s): | TRANSDERMAL |
Dosage Form(s): | PATCH |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 52544-473 |
Labeler Name: | Watson Pharma, Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA020655 |
Marketing Category: | NDA |
Start Marketing Date: | 19961220 |
Package NDC: | 52544-473-08 |
Package Description: | 8 POUCH in 1 BOX (52544-473-08) > 1 PATCH in 1 POUCH > 3.5 d in 1 PATCH |
NDC Code | 52544-473-08 |
Proprietary Name | Alora |
Package Description | 8 POUCH in 1 BOX (52544-473-08) > 1 PATCH in 1 POUCH > 3.5 d in 1 PATCH |
Product NDC | 52544-473 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Estradiol Transdermal System |
Dosage Form Name | PATCH |
Route Name | TRANSDERMAL |
Start Marketing Date | 19961220 |
Marketing Category Name | NDA |
Labeler Name | Watson Pharma, Inc. |
Substance Name | ESTRADIOL |
Strength Number | .1 |
Strength Unit | mg/d |
Pharmaceutical Classes | Estradiol Congeners [Chemical/Ingredient],Estrogen [EPC],Estrogen Receptor Agonists [MoA] |